{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:54:53Z","timestamp":1771862093008,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ahj.2020.05.004","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:44:51Z","timestamp":1589197491000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?"],"prefix":"10.1016","volume":"226","author":[{"given":"Andrew C.T.","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2020.05.004_bb0005","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.hrthm.2004.04.025","article-title":"Quality of life as an endpoint for atrial fibrillation research: pitfalls and practice","volume":"1","author":"Newman","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2020.05.004_bb0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease2010Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0020","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.05.004_bb0025","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO). Europace. 2016;pii:euw295."},{"key":"10.1016\/j.ahj.2020.05.004_bb0030","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0195-668X(03)00261-6","article-title":"Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation Results from a prospective randomized study","volume":"24","author":"Gr\u00f6nefeld","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","article-title":"RACE Study Group. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study","volume":"43","author":"Hagens","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2004.03.065","article-title":"Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"Jenkins","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0045","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/hrt.2008.158931","article-title":"A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)","volume":"95","author":"Shelton","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2020.05.004_bb0050","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2012.10.031","article-title":"Khairy P; AF-CHF Trial Investigators. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure","volume":"61","author":"Suman-Horduna","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0060","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/HCQ.0000000000000011","volume":"7","author":"Ha","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2020.05.004_bb0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2012.12.019","article-title":"Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"165","author":"Steinberg","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2006.03.051","article-title":"Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy","volume":"48","author":"Singh","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/CIRCEP.108.812347","article-title":"Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale","volume":"2","author":"Dorian","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ahj.2013.04.015","article-title":"Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?","volume":"166","author":"Dorian","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0095","first-page":"450","article-title":"Impact of electrical cardioversion on quality of life for the treatment of atrial fibrillation","volume":"33","author":"Sandhu","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2016.10.018","article-title":"Cardioversion and subsequent quality of life and natural history of atrial fibrillation","volume":"185","author":"Pokorney","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjmed.2006.05.046","article-title":"The expectation effect and cardiac pacing for refractory vasovagal syncope","volume":"120","author":"Sud","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2020.05.004_bb0110","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.05.004_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2020.05.004_bb0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2006.09.036","article-title":"Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship","volume":"49","author":"Olshansky","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0130","first-page":"1535","article-title":"The placebo effect in cardiology: understanding and using it","volume":"33","author":"Sheldon","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2020.05.004_bb0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ahj.2008.06.010","article-title":"ERATO Study Investigators. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ahj.2009.09.007","article-title":"Rienstra M, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC; RACE investigators. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study","volume":"158","author":"Groenveld","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.05.004_bb0145","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2011.06.055","article-title":"The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study","volume":"58","author":"Groenveld","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032030140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032030140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:05:19Z","timestamp":1757570719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032030140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":28,"alternative-id":["S000287032030140X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.05.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}